Patent details

Basic Information

Publication number:

EP2325305

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP100104389

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides

French Title of Invention:

Vaccins à base de peptides pour cancers du poumon exprimant des polypeptides TTK, URLC10 ou KOC1

German Title of Invention:

Peptid-Impfstoff für Lungenkrebs, der TTK, URLC10 oder KOC1 Polypeptide exprimiert

SPC Number:

Dates

Filing date:

17/02/2006

Grant date:

12/02/2014

EP Publication Date:

12/02/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/05/2011

EP B1 Publication Date:

12/02/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/02/2014

Expiration date:

17/02/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/02/2006

 

 

Name:

Oncotherapy Science Inc.

Address:

2-1, Sakado 3-chome Takatsu-ku, Kawasaki-shi Kanagawa 213-0012, Japan (JP)

Inventor

1

Name:

Nakamura Yusuke

Address:

Japan (JP)

2

Name:

Tsunoda Takuya

Address:

Japan (JP)

3

Name:

Tahara Hideaki

Address:

Japan (JP)

4

Name:

Nakatsuru Shuichi

Address:

Japan (JP)

5

Name:

Daigo Yataro

Address:

Japan (JP)

Priority

Priority Number:

656857 P

Priority Date:

25/02/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 9/12;

Filing date	Document type	Number of pages